DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
 News | News By Subject | News By Date | Search News
Get Our Industry eNewsletter FREE email:    
 Print  Email    

Medtronic, Inc. (MDT) Recall Gets Class I Status From FDA


12/27/2012 6:31:20 AM

The FDA slapped Medtronic's (NYSE:MDT) recall with Class I status over concerns that the medical device maker's SynchroMed II infusion pumps may fail in certain circumstances. Medtronic initiated a recall on the devices in November after finding higher-than-expected rates of failure when the implantable SynchroMed II pumps were used with "unapproved drugs." "Based on data from the firm's Implantable Systems Performance Registry, the overall failure rate of the SynchroMed II pump at 78 months post implant is 2.4% when used to dispense approved drugs, and 7.0% when used to dispense unapproved drugs," according to the FDA notice. "The use of unapproved drugs can lead to intermittent or permanent pump motor stall and cessation of drug infusion."

Read at MassDevice
Read at Star Tribune
Read at News Release
Read at MedPageToday

 Read Article at  Related Companies  News Categories
   


ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 
    

//-->